Mr Carl Gibson, chief executive of Comeplementary Medicines Australia (CMA) has welcomed the results of a Cochrane Review of chondroitin sulfate that confirm the efficacy and safety of this supplement in the treatment of Osteoarthritis (OA).
Read the media release here